These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 8280722)
1. The lymphatic route. IX. Distribution of recombinant interferon-alpha 2 administered subcutaneously with oedematogenic drugs. Pessina GP; Bocci V; Carraro F; Naldini A; Paulesu L Physiol Res; 1993; 42(4):243-50. PubMed ID: 8280722 [TBL] [Abstract][Full Text] [Related]
2. The lymphatic route. VI. Distribution of recombinant interferon-alpha 2 in rabbit and pig plasma and lymph. Bocci V; Pessina GP; Paulesu L; Nicoletti C J Biol Response Mod; 1988 Aug; 7(4):390-400. PubMed ID: 3171601 [TBL] [Abstract][Full Text] [Related]
3. The lymphatic route--II. Pharmacokinetics of human recombinant interferon-alpha 2 injected with albumin as a retarder in rabbits. Bocci V; Muscettola M; Naldini A; Bianchi E; Segre G Gen Pharmacol; 1986; 17(1):93-6. PubMed ID: 3949153 [TBL] [Abstract][Full Text] [Related]
4. The lymphatic route--III. Pharmacokinetics of human natural interferon-beta injected with albumin as a retarder in rabbits. Bocci V; Muscettola M; Naldini A Gen Pharmacol; 1986; 17(4):445-8. PubMed ID: 3758650 [TBL] [Abstract][Full Text] [Related]
5. The lymphatic route. V. Distribution of human natural interferon-beta in rabbit plasma and lymph. Bocci V; Pessina GP; Paulesu L; Muscettola M; Valeri A J Interferon Res; 1988 Oct; 8(5):633-40. PubMed ID: 3235848 [TBL] [Abstract][Full Text] [Related]
6. Choroidal concentration of interferon after retrobulbar injection. Lincoff H; Stanga P; Movshovich A; Palleroni A; Madjarov B; Rivera R; Silverman R Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2768-71. PubMed ID: 8977493 [TBL] [Abstract][Full Text] [Related]
7. Effect of molecular weight on the lymphatic absorption of water-soluble compounds following subcutaneous administration. Supersaxo A; Hein WR; Steffen H Pharm Res; 1990 Feb; 7(2):167-9. PubMed ID: 2137911 [TBL] [Abstract][Full Text] [Related]
8. Lymphatic absorption is the primary contributor to the systemic availability of epoetin Alfa following subcutaneous administration to sheep. McLennan DN; Porter CJ; Edwards GA; Martin SW; Heatherington AC; Charman SA J Pharmacol Exp Ther; 2005 Apr; 313(1):345-51. PubMed ID: 15579493 [TBL] [Abstract][Full Text] [Related]
9. Lymphatic transport and catabolism of therapeutic proteins after subcutaneous administration to rats and dogs. Wang W; Chen N; Shen X; Cunningham P; Fauty S; Michel K; Wang B; Hong X; Adreani C; Nunes CN; Johnson CV; Yin KC; Groff M; Zou Y; Liu L; Hamuro L; Prueksaritanont T Drug Metab Dispos; 2012 May; 40(5):952-62. PubMed ID: 22328584 [TBL] [Abstract][Full Text] [Related]
10. Bioequivalence of two subcutaneous pharmaceutical products of interferon beta la. Di Girolamo G; Kauffman MA; González E; Papouchado M; Ramírez A; Keller G; Carbonetto C; Dabsys S; Vidal A; Sterin-Prync A; Diez RA Arzneimittelforschung; 2008; 58(4):193-8. PubMed ID: 18540482 [TBL] [Abstract][Full Text] [Related]
11. The lymphatic route. VII. Distribution of recombinant human interleukin-2 in rabbit plasma and lymph. Bocci V; Pessina GP; Nicoletti C; Paulesu L J Biol Regul Homeost Agents; 1990; 4(1):25-9. PubMed ID: 2399833 [TBL] [Abstract][Full Text] [Related]
12. The lymphatic route. 1) Albumin and hyaluronidase modify the normal distribution of interferon in lymph and plasma. Bocci V; Muscettola M; Grasso G; Magyar Z; Naldini A; Szabo G Experientia; 1986 Apr; 42(4):432-3. PubMed ID: 3956696 [TBL] [Abstract][Full Text] [Related]
13. Herpes simplex virus induces appearance of interferon-alpha/beta-producing cells and partially interferon-alpha/beta-dependent accumulation of leukocytes in murine regional lymph nodes. Riffault S; Eloranta ML; Carrat C; Sandberg K; Charley B; Alm G J Interferon Cytokine Res; 1996 Dec; 16(12):1007-14. PubMed ID: 8974002 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of interferon alpha-2b in healthy volunteers. Radwanski E; Perentesis G; Jacobs S; Oden E; Affrime M; Symchowicz S; Zampaglione N J Clin Pharmacol; 1987; 27(5):432-5. PubMed ID: 3693589 [TBL] [Abstract][Full Text] [Related]
15. Effect of interferon-alpha-2a on the output of recirculating lymphocytes from single lymph nodes. Hein WR; Supersaxo A Immunology; 1988 Jul; 64(3):469-74. PubMed ID: 3410492 [TBL] [Abstract][Full Text] [Related]
16. Plasma and tissue pharmacokinetics of human interferon-alpha in the rat after its intravenous administration. Greig NH; Soncrant TT; Wozniak KM; Rapoport SI J Pharmacol Exp Ther; 1988 May; 245(2):574-80. PubMed ID: 2835475 [TBL] [Abstract][Full Text] [Related]
17. Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats. Kim CK; Han JH J Microencapsul; 1995; 12(4):437-46. PubMed ID: 8583318 [TBL] [Abstract][Full Text] [Related]
18. The transmucosal absorption of recombinant human interferon-alpha B/D hybrid in the rat and rabbit. Bayley D; Temple C; Clay V; Steward A; Lowther N J Pharm Pharmacol; 1995 Sep; 47(9):721-4. PubMed ID: 8583382 [TBL] [Abstract][Full Text] [Related]
19. Systemic availability and lymphatic transport of human growth hormone administered by subcutaneous injection. Charman SA; Segrave AM; Edwards GA; Porter CJ J Pharm Sci; 2000 Feb; 89(2):168-77. PubMed ID: 10688746 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of human recombinant interferon-beta in monkeys and rabbits. Gomi K; Morimoto M; Inoue A; Kobayashi H; Deguchi T; Hara T; Nakamizo N Gan; 1984 Mar; 75(3):292-300. PubMed ID: 6724230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]